Position in LLY
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$27,965,606
-$4,238,257 QoQ
Shares Held
30,405
+1.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Parallel Advisors, LLC holds $104,513,791 across 18 Drug Manufacturers - General names. LLY ranks #1 (26.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
30,405 | $27,965,606 | |
| 2 | ABBV |
AbbVie Inc.
|
103,875 | $22,591,773 | |
| 3 | JNJ |
Johnson & Johnson
|
80,406 | $19,654,442 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
75,984 | $10,589,890 | |
| 5 | MRK |
Merck & Co., Inc.
|
56,169 | $6,756,569 | |
| 6 | PFE |
Pfizer Inc
|
129,199 | $3,627,907 | |
| 7 | AMGN |
Amgen Inc
|
10,183 | $3,582,888 | |
| 8 | NVS |
Novartis AG
|
16,366 | $2,499,906 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,965,606 | 30,405 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $32,203,863 | 29,966 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $22,292,571 | 29,217 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $22,202,573 | 28,482 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $23,929,090 | 28,973 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $20,285,844 | 26,277 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $20,951,595 | 23,649 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $21,976,288 | 24,273 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $18,473,438 | 23,746 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $13,503,924 | 23,166 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $12,386,217 | 23,060 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $10,658,508 | 22,727 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $7,559,704 | 22,013 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $7,451,794 | 20,369 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $6,405,563 | 19,810 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $6,284,874 | 19,384 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $5,492,003 | 19,178 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $4,315,108 | 15,622 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $3,458,587 | 14,969 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $3,878,658 | 16,899 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $3,056,375 | 16,360 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $2,246,247 | 13,304 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $2,295,198 | 15,506 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $2,527,879 | 15,397 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $2,470,187 | 17,807 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||